PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/6/2007

PHARMANIAGA BERHAD

Financial Year End

31/12/2007
Quarter2
Quarterly report for the financial period ended30/06/2007
The figureshave not been audited

Attachments

pharmaniaga_bursa_0706 (2).pdf
102 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2007

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/06/2007
30/06/2006
30/06/2007
30/06/2006
RM'000
RM'000
RM'000
RM'000
1Revenue
300,231
251,133
556,466
501,887
2Profit/(loss) before tax
12,181
8,266
22,411
17,177
3Profit/(loss) for the period
7,217
6,084
13,710
11,813
4Profit/(loss) attributable to ordinary equity holders of the parent
6,640
5,663
12,709
10,935
5Basic earnings/(loss) per share (sen)
6.21
5.29
11.88
10.22
6Proposed/Declared dividend per share (sen)
15.00
11.50
15.00
11.50
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
2.9400
2.9700

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
The Directors do not recommend any payment of interim dividend for the current financial period ended 30 June 2007 (2006:nil).


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced17 Aug 2007  
CategoryFinancial Results
Reference NoPB-070815-52223